Related Experiment Videos
Serum tumour markers and management of non-small cell lung cancer
1Department of Medical Oncology, University Hospital Dijkzigt, Rotterdam, The Netherlands.
Lung Cancer (Amsterdam, Netherlands)
|October 1, 1995
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Arterial occlusive events during chemotherapy for germ cell cancer.
The Netherlands journal of medicine·2001
Is there a common etiology for the rising incidence of and decreasing survival with adenocarcinoma of the lung?
Epidemiology (Cambridge, Mass.)·2001
The urokinase-type plasminogen activator system in resected non-small-cell lung cancer. Rotterdam Oncology Thoracic Study Group.
Annals of oncology : official journal of the European Society for Medical Oncology·2000
Multi-omics liquid biopsy for leptomeningeal metastases in lung cancer: from molecular mechanisms to precision diagnosis and treatment.
Lung cancer (Amsterdam, Netherlands)·2026
Efficacy and safety of adjuvant ensartinib in stage I ALK-positive NSCLC patients: a retrospective, multicenter study.
Lung cancer (Amsterdam, Netherlands)·2026
TLS-related immune organization and regional IRF4 expression in pretreatment biopsies of advanced lung adenocarcinoma.
Lung cancer (Amsterdam, Netherlands)·2026
Lung cytology in the diagnostic workflow: A real-world study of its clinical impact.
Lung cancer (Amsterdam, Netherlands)·2026
Trial-specific absolute disease-free survival effects of postoperative PD-1/PD-L1 blockade after complete resection of NSCLC: A systematic review.
Lung cancer (Amsterdam, Netherlands)·2026
Exploratory analysis of extracellular vesicle Profile changes during pembrolizumab treatment in NSCLC.
Lung cancer (Amsterdam, Netherlands)·2026
ER-/PR+ breast cancer: from diagnostic discordance to precision therapy.
Frontiers in oncology·2026
Non-Invasive Detection of Opioid Addiction through Serum Analysis Using FTIR Spectroscopy.
Addiction & health·2026